MustBio Co., Ltd.
- Biotech or pharma, therapeutic R&D
Mustbio develops first-in-class and best-in-class, highly tumor-selective immuno-cytokines. Our mission is to precisely harness the power of the immune system, addressing the limitations of conventional cytokine therapies with their narrow safety margins and overcoming the challenges posed by immunotherapies that are ineffective in cold tumors. Founded by a team of experts with extensive experience in new drug development, our goal is to create groundbreaking immuno-oncology therapies to address the significant unmet needs of cancer patients worldwide.